Suchergebnisse - (Subject:"Siltuximab")

PubPharm (226)

221

Clinical and correlative results of SWOG S0354 : a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Dorff, T. | Goldman, B. | Pinski, J. | +7

222

Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Puchalski, T. | Prabhakar, U. | Jiao, Q. | +2

223

Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death

enthalten in: British journal of haematology | 2009

von Voorhees, P. | Chen, Q. | Small, G. | +4

224

Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma

enthalten in: Advances in experimental medicine and biology | 2008

von Cavarretta, I. | Neuwirt, H. | Zaki, M. | +4

225

The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1

enthalten in: Oncogene | 2007

von Cavarretta, I. | Neuwirt, H. | Untergasser, G. | +8

226

CNTO-328 (Centocor)

enthalten in: Current opinion in investigational drugs (London, England : 2000) | 2005

von Li, J. | Hu, X. | Xing, P.

[1]
« Vorheriger
13
14
15
16
17
18
19
20
21
22
23